• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOUSSE:使用特定个体特征的多组学技术

MOUSSE: Multi-Omics Using Subject-Specific SignaturEs.

作者信息

Fiorentino Giuseppe, Visintainer Roberto, Domenici Enrico, Lauria Mario, Marchetti Luca

机构信息

Fondazione The Microsoft Research, University of Trento Centre for Computational and Systems Biology (COSBI), 38068 Rovereto, Italy.

Department of Cellular, Computational, and Integrative Biology (CiBio), University of Trento, 38123 Povo, Italy.

出版信息

Cancers (Basel). 2021 Jul 8;13(14):3423. doi: 10.3390/cancers13143423.

DOI:10.3390/cancers13143423
PMID:34298641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8304726/
Abstract

High-throughput technologies make it possible to produce a large amount of data representing different biological layers, examples of which are genomics, proteomics, metabolomics and transcriptomics. Omics data have been individually investigated to understand the molecular bases of various diseases, but this may not be sufficient to fully capture the molecular mechanisms and the multilayer regulatory processes underlying complex diseases, especially cancer. To overcome this problem, several multi-omics integration methods have been introduced but a commonly agreed standard of analysis is still lacking. In this paper, we present MOUSSE, a novel normalization-free pipeline for unsupervised multi-omics integration. The main innovations are the use of rank-based subject-specific signatures and the use of such signatures to derive subject similarity networks. A separate similarity network was derived for each omics, and the resulting networks were then carefully merged in a way that considered their informative content. We applied it to analyze survival in ten different types of cancer. We produced a meaningful clusterization of the subjects and obtained a higher average classification score than ten state-of-the-art algorithms tested on the same data. As further validation, we extracted from the subject-specific signatures a list of relevant features used for the clusterization and investigated their biological role in survival. We were able to verify that, according to the literature, these features are highly involved in cancer progression and differential survival.

摘要

高通量技术使得生成大量代表不同生物层面的数据成为可能,其中包括基因组学、蛋白质组学、代谢组学和转录组学等。为了理解各种疾病的分子基础,人们对组学数据进行了单独研究,但这可能不足以充分捕捉复杂疾病(尤其是癌症)背后的分子机制和多层调控过程。为了克服这个问题,人们引入了几种多组学整合方法,但仍缺乏一个普遍认可的分析标准。在本文中,我们提出了MOUSSE,这是一种用于无监督多组学整合的新型无归一化流程。主要创新点在于使用基于秩的个体特异性特征以及利用这些特征推导个体相似性网络。针对每个组学都推导了一个单独的相似性网络,然后以一种考虑其信息内容的方式仔细合并所得网络。我们将其应用于分析十种不同类型癌症的生存率。我们对个体进行了有意义的聚类,并获得了比在相同数据上测试的十种先进算法更高的平均分类分数。作为进一步的验证,我们从个体特异性特征中提取了用于聚类的相关特征列表,并研究了它们在生存中的生物学作用。根据文献,我们能够验证这些特征与癌症进展和差异生存高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/24344e5af1bc/cancers-13-03423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/d7a465a2a1bc/cancers-13-03423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/e3322b8d465a/cancers-13-03423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/24344e5af1bc/cancers-13-03423-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/d7a465a2a1bc/cancers-13-03423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/e3322b8d465a/cancers-13-03423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b563/8304726/24344e5af1bc/cancers-13-03423-g003.jpg

相似文献

1
MOUSSE: Multi-Omics Using Subject-Specific SignaturEs.MOUSSE:使用特定个体特征的多组学技术
Cancers (Basel). 2021 Jul 8;13(14):3423. doi: 10.3390/cancers13143423.
2
The Need for Multi-Omics Biomarker Signatures in Precision Medicine.精准医学中多组学生物标志物特征的必要性。
Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.
3
A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.一种详细的多组学方法目录,用于鉴定转化癌症研究中的潜在生物标志物和因果分子网络。
Int J Mol Sci. 2021 Mar 10;22(6):2822. doi: 10.3390/ijms22062822.
4
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
5
Integration of Online Omics-Data Resources for Cancer Research.整合用于癌症研究的在线组学数据资源。
Front Genet. 2020 Oct 23;11:578345. doi: 10.3389/fgene.2020.578345. eCollection 2020.
6
Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.在整合的平行多组学数据集中识别1型糖尿病复合生物标志物特征的监督参数学习
Biomedicines. 2024 Feb 22;12(3):492. doi: 10.3390/biomedicines12030492.
7
Integration strategies of multi-omics data for machine learning analysis.用于机器学习分析的多组学数据整合策略。
Comput Struct Biotechnol J. 2021 Jun 22;19:3735-3746. doi: 10.1016/j.csbj.2021.06.030. eCollection 2021.
8
Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.阿尔茨海默病系统生物学中的组学科学:证据的最新进展。
Ageing Res Rev. 2021 Aug;69:101346. doi: 10.1016/j.arr.2021.101346. Epub 2021 Apr 27.
9
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data.通过整合多组学数据,为个体化抗癌药物反应鉴定亚途径特征。
J Transl Med. 2019 Aug 6;17(1):255. doi: 10.1186/s12967-019-2010-4.
10
Omics for the future in asthma.哮喘领域未来的组学研究
Semin Immunopathol. 2020 Feb;42(1):111-126. doi: 10.1007/s00281-019-00776-x. Epub 2020 Jan 15.

引用本文的文献

1
Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review.揭示癌症研究与治疗中患者相似性概念的理解:范围综述
J Med Internet Res. 2025 Aug 18;27:e71906. doi: 10.2196/71906.
2
Multi-Omics Data Analysis Identifies Prognostic Biomarkers across Cancers.多组学数据分析鉴定癌症预后生物标志物。
Med Sci (Basel). 2023 Jun 27;11(3):44. doi: 10.3390/medsci11030044.
3
Overview of methods for characterization and visualization of a protein-protein interaction network in a multi-omics integration context.

本文引用的文献

1
Open Targets Platform: supporting systematic drug-target identification and prioritisation.Open Targets 平台:支持系统性药物靶点识别和优先级排序。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1302-D1310. doi: 10.1093/nar/gkaa1027.
2
Association of miR-760 with cancer: An overview.miR-760 与癌症的关联:概述。
Gene. 2020 Jul 15;747:144648. doi: 10.1016/j.gene.2020.144648. Epub 2020 Apr 3.
3
The mir-767-105 cluster: a crucial factor related to the poor prognosis of hepatocellular carcinoma.mir-767-105基因簇:与肝细胞癌预后不良相关的关键因素。
多组学整合背景下蛋白质-蛋白质相互作用网络的表征与可视化方法概述。
Front Mol Biosci. 2022 Sep 8;9:962799. doi: 10.3389/fmolb.2022.962799. eCollection 2022.
Biomark Res. 2020 Feb 13;8:7. doi: 10.1186/s40364-020-0186-7. eCollection 2020.
4
Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.一种三基因特征作为低级别胶质瘤候选预后生物标志物的鉴定与验证
PeerJ. 2020 Jan 3;8:e8312. doi: 10.7717/peerj.8312. eCollection 2020.
5
Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.在经历了母体分离的弗林德斯敏感系大鼠中,抗抑郁治疗反应/无反应的基因表达特征。
Eur Neuropsychopharmacol. 2020 Feb;31:69-85. doi: 10.1016/j.euroneuro.2019.11.004. Epub 2019 Dec 6.
6
LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression.长链非编码RNA LINC00963通过海绵化miR-324-3p并诱导ACK1表达促进乳腺癌的肿瘤发生和放射抗性。
Mol Ther Nucleic Acids. 2019 Dec 6;18:871-881. doi: 10.1016/j.omtn.2019.09.033. Epub 2019 Oct 22.
7
Integrative approaches to reconstruct regulatory networks from multi-omics data: A review of state-of-the-art methods.从多组学数据重建调控网络的综合方法:最新方法综述。
Comput Biol Chem. 2019 Dec;83:107120. doi: 10.1016/j.compbiolchem.2019.107120. Epub 2019 Sep 6.
8
Nek2 augments sorafenib resistance by regulating the ubiquitination and localization of β-catenin in hepatocellular carcinoma.Nek2 通过调节肝癌细胞中β-catenin 的泛素化和定位来增强索拉非尼耐药性。
J Exp Clin Cancer Res. 2019 Jul 18;38(1):316. doi: 10.1186/s13046-019-1311-z.
9
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.鉴定 SEC61G 作为胶质母细胞瘤患者生存和治疗反应的新型预后标志物。
Med Sci Monit. 2019 May 16;25:3624-3635. doi: 10.12659/MSM.916648.
10
NEMO: cancer subtyping by integration of partial multi-omic data.NEMO:通过整合部分多组学数据进行癌症亚型分类。
Bioinformatics. 2019 Sep 15;35(18):3348-3356. doi: 10.1093/bioinformatics/btz058.